Key Considerations When Choosing a First-Line Treatment Option for Unresectable Hepatocellular Carcinoma

Nov 17 2024

Convention Center: Exhibit Hall B - TLM Theater 2

10:00 AM - 10:45 AM

World Class Speakers

Industry Presenter

Pierre M. Gholam, MD

Case western reserve university school of medicine

Description

This presentation will cover important factors in selecting a first-line treatment option for patients with unresectable hepatocellular carcinoma (HCC). It will explore the efficacy and safety from a clinical trial, including the latest evidence from recent analyses.

Industry Supporter: AstraZeneca

Presentations

3:49 PM - 3:49 PM

Nov 17 2024

San Diego, CA

Key Considerations When Choosing a First-Line Treatment Option for Unresectable Hepatocellular Carcinoma

Pierre M. Gholam, MD, Industry Presenter